Shield Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsShield Therapeutics

Shield Therapeutics

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Accrufer	Ferric maltol	2019-07-25	2031-2035	Iron-deficiency anemia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

atopic dermatitis

,

myeloid leukemia acute

,

multiple myeloma

,

,

plasma cell neoplasms

,

large b-cell lymphoma diffuse

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

opioid-related disorders

,

alzheimer disease

,

huntington disease

,

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

,

,

triple negative breast neoplasms

,

serogroup b neisseria meningitidis

,

,

urologic neoplasms

,

urinary bladder neoplasms

,

urologic diseases

,

urinary bladder diseases

,

,

,

cognitive dysfunction

,

central nervous system neoplasms

,

solitary fibrous tumors

,

neurofibromatosis 1

,

neurofibromatoses

,

hemangioblastoma

,

hemangiopericytoma

,

,

streptococcal infections

,

thyroid neoplasms

,

thyroid diseases

,

,

breast neoplasms

,

sickle cell anemia

,

,

renal insufficiency

,

,

,

rheumatoid arthritis

,

,

bacterial pneumonia

,

juvenile arthritis

,

psoriatic arthritis

,

ankylosing spondylitis

,

carotid artery diseases

,

atherosclerosis

,

ulcerative colitis

,

,

meningococcal meningitis

,

,

thromboembolism

,

,

,

acquired immunodeficiency syndrome

,

immune reconstitution inflammatory syndrome

,

,

alopecia areata

,

,

,

healthy volunteers/patients

,

,

communicable diseases

,

intraabdominal infections

,

smoking cessation

,

neuroendocrine tumors

,

islet cell adenoma

,

psychomotor agitation

,

,

renal cell carcinoma

,

,

gaucher disease

,

tobacco use disorder

,

,

,

,

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

,

pulmonary edema

,

,

squamous cell carcinoma

,

squamous cell neoplasms

,

prostatic neoplasms

,

peritoneal neoplasms

,

breast neoplasms

,

,

,

ovarian neoplasms

,

acquired immunodeficiency syndrome

,

,

communicable diseases

,

neoplasm metastasis

,

,

,

premature obstetric labor

,

,

ovarian epithelial carcinoma

,

overactive urinary bladder

,

non-small-cell lung carcinoma

,

chronic renal insufficiency

,

kidney diseases

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

,

,

head and neck neoplasms

,

renal cell carcinoma

,

,

urinary tract infections

,

,

non-hodgkin lymphoma

,

fallopian tube neoplasms

,

endometrial neoplasms

,

erectile dysfunction

,

,

muscle spasticity

,

urinary incontinence

,

,

postmenopausal osteoporosis

,

stomach neoplasms

,

gastrointestinal neoplasms

,

acute coronary syndrome

,

,

parkinson disease

,

respiratory tract diseases

,

orthomyxoviridae infections

,

human influenza

,

,

,

brain neoplasms

,

small cell lung carcinoma

,

,

venous thrombosis

,

thrombophlebitis

,

,

postoperative nausea and vomiting

,

post-traumatic stress disorders

,

traumatic stress disorders

,

,

,

,

triple negative breast neoplasms

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

immunologic deficiency syndromes

,

atherosclerosis

,

,

,

systemic lupus erythematosus

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use